|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0022671,
umls-concept:C0034656,
umls-concept:C0035015,
umls-concept:C0036043,
umls-concept:C0205178,
umls-concept:C0209368,
umls-concept:C0442027,
umls-concept:C0681867,
umls-concept:C0683150,
umls-concept:C1548437,
umls-concept:C1708528,
umls-concept:C1882923
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-8-17
|
|
pubmed:abstractText |
Adding a fixed dose of 1 g b.i.d. of mycophenolate mofetil (MMF) to an immunosuppressive regimen consisting of cyclosporine and prednisone results in a 50% reduction in the incidence of acute rejection after kidney transplantation. This study was designed to investigate the relationship between pharmacokinetic data (mycophenolic acid area under the curve; MPA AUC) and the prevention of rejection after kidney transplantation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:HallM MMM,
pubmed-author:HermR JRJ,
pubmed-author:HilbrandsL BLB,
pubmed-author:NavarroM TMT,
pubmed-author:NichollsA JAJ,
pubmed-author:SquiffletJ PJP,
pubmed-author:VanrenterghemYY,
pubmed-author:VerpootenG AGA,
pubmed-author:WeimarWW,
pubmed-author:de FijterJ WJW,
pubmed-author:van GelderTT
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10440399-Acute Disease,
pubmed-meshheading:10440399-Administration, Oral,
pubmed-meshheading:10440399-Adult,
pubmed-meshheading:10440399-Cyclosporine,
pubmed-meshheading:10440399-Drug Therapy, Combination,
pubmed-meshheading:10440399-Female,
pubmed-meshheading:10440399-Graft Rejection,
pubmed-meshheading:10440399-Graft Survival,
pubmed-meshheading:10440399-Humans,
pubmed-meshheading:10440399-Immunosuppressive Agents,
pubmed-meshheading:10440399-Incidence,
pubmed-meshheading:10440399-Kidney,
pubmed-meshheading:10440399-Kidney Transplantation,
pubmed-meshheading:10440399-Logistic Models,
pubmed-meshheading:10440399-Male,
pubmed-meshheading:10440399-Middle Aged,
pubmed-meshheading:10440399-Mycophenolic Acid,
pubmed-meshheading:10440399-Opportunistic Infections,
pubmed-meshheading:10440399-Pharmacokinetics,
pubmed-meshheading:10440399-Pharmacology,
pubmed-meshheading:10440399-Prednisone,
pubmed-meshheading:10440399-Severity of Illness Index,
pubmed-meshheading:10440399-Survival Rate
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
|
|
pubmed:affiliation |
Department of Internal Medicine I, University Hospital Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
